This content is intended for healthcare professionals in Australia, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Sweden, Switzerland & UK only.

Please confirm that you are a healthcare professional in one of those countries.

Decline

This activity has been sponsored by Insulet.

Insulet provided financial support and video content, and has had input into the detailed project scope. This activity is provided by Touch Medical Communications (TMC) for touchENDOCRINOLOGY.

touchENDOCRINOLOGY touchENDOCRINOLOGY
Start activity
 
                                        

                                        

                                        

                                        

                                        

                                        

                                        

Video Chapters
Take CE/CME Test

touchMEETING HIGHLIGHTS

Automated insulin delivery (AID) in children with type 1 diabetes: Outcomes and education strategies in real-world practice

Learning Objectives

After watching this activity, participants should be better able to:

  • Assess clinical and quality of life outcomes associated with AID use in children
  • Recognise individualised educational strategies for children with diverse needs starting AID
  • Understand the real-world impact of AID technology in children with diabetes and their parents
Overview

Blood glucose control in children with type 1 diabetes requires constant monitoring along with appropriate insulin dosing to achieve glycaemic goals, maximise time in range (TIR) and avoid hypoglycaemia.1 Glucose control is particularly important for children with diabetes, since suboptimal control may affect cognitive function and quality of life.2 Automated insulin delivery (AID), which includes a pump to automate insulin delivery, continuous glucose monitoring and a control algorithm, provides improvements in glycaemic control and TIR,3 while enabling users and caregivers to be less burdened by diabetes.4 Diabetes treatment guidelines recommend AID for children who are capable and appropriately trained,4,5 highlighting the need for educational strategies to maximise access to this technology.

References 

  1. Chiang JL, Maahs DM, Garvey KC, et al. Type 1 diabetes in children and adolescents: A position statement by the American Diabetes Association. Diabetes Care. 2018;41:2026-44.
  2. de Bock M, Agwu JC, Deabreu M, et al. International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2024: Glycemic targets. Horm Res Paediatr. 2024;97:650-8.
  3. Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis. BMJ. 2018;361:k1310.
  4. Sherr JL, Heinemann L, Fleming G, et al. Automated insulin delivery: Benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia. 2023;66:3-22.
  5. Biester T, Berget C, Boughton C, et al. International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2024: Diabetes technologies - insulin delivery. Horm Res Paediatr 2024;97:592-618.
  • Faculty information is available in the Toolkit.

Topics covered in this activity

Diabetes / Paediatric Endocrinology

Topics covered in this activity

Diabetes / Paediatric Endocrinology
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup